Answers are grounded in this paper and cite their sources.
Demonstrates increased donor heart protection and improved function using siRNA nanoparticles, suggesting a new approach for cardiac transplants.
Heart transplantation is an optimal therapeutic regimen for terminal-stage cardiac failure. However, cold ischemia-reperfusion injury (CIRI) remains an unavoidable and outstanding challenge, which is a significant obstacle to early graft dysfunction and long-term survival. Blockage of complement, apoptosis, and inflammation by small interfering RNA is considered a strategy for attenuating CIRI and protecting cardiac function. However, their delivery to the donor organ is still a serious challenge due to the polyanionic nature and high molecular weight properties. Here, we have designed a novel functionalized gene delivery system of direct delivery and sustained release of siRNAs targeting complement C3 (C3), Caspase-3, and nuclear factor κB (NF-κB) to treat the donor organ prior to transplantation. The functionalized gene delivery system (siRNA-TNPs), composed of CaCO3/CaP/TAT embellished carboxymethyl chitosan (CaCO3/CaP/TCMC) and synthesized through the co-precipitation method, efficiently encapsulates siRNAs during self-assembly. The siRNA-TNPs safeguards siRNAs from biological degradation, facilitates intracellular siRNA transfection, promotes lysosomal escape, and enhanced the delivery efficiency of siRNA to the donor hearts. Perfusion of donor hearts with siRNA-TNPs prior to transplantation attenuated C3, Caspase-3, and NF-κB genes expression of donor heart for at least 5 days after transplantation. Furthermore, silencing of C3, Caspase-3, and NF-κB genes expression alleviated cell apoptosis, myocardial damage, tissue inflammation, and rejection and improved cardiac function. These data suggest that the multiple-target siRNA-TNPs solution can extend the preservation time for donor grafts, attenuate IRI, and protect cardiac function in murine models of heart transplantation, which provides a principal of concept for potential clinical translation.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: